NDLI: Glucose control in non-critically ill inpatients with diabetes: towards closed-loop.

Please wait, while we are loading the content...

Comparison of insulin lispro protamine suspension versus insulin glargine once daily added to oral antihyperglycaemic medications and exenatide in type 2 diabetes: a prospective randomized open-label trial.

Atorvastatin plus omega-3 fatty acid ethyl ester decreases very-low-density lipoprotein triglyceride production in insulin resistant obese men.

The dipeptidylpeptidase-IV inhibitors sitagliptin, vildagliptin and saxagliptin do not impair innate and adaptive immune responses.

Differing effects of liraglutide on gastric emptying in Japanese patients with type 2 diabetes.

A randomized controlled trial comparing the GLP-1 receptor agonist liraglutide to a sulphonylurea as add on to metformin in patients with established type 2 diabetes during Ramadan: the Treat 4 Ramadan Trial.

APOE*3Leiden.CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome.

Postprandial effects of long-term niacin/laropiprant use on glucose and lipid metabolism and on cardiovascular risk in patients with polycystic ovary syndrome.

How many people inject insulin? UK estimates from 1991 to 2010.

Linagliptin treatment in subjects with type 2 diabetes with and without mild-to-moderate renal impairment.

Year: 2014 Volume: 16 Issue: 5

Year: 2014 Volume: 16 Issue: 4

Year: 2014 Volume: 16 Issue: 3

Year: 2014 Volume: 16 Issue: 2

Year: 2014 Volume: 16 Issue: 1

Year: 2014 Volume: 16 Issue: Supplementary 1

Year: 2013 Volume: 15

Year: 2012 Volume: 14

Year: 2011 Volume: 13

Year: 2010 Volume: 12

Year: 2009 Volume: 11

Year: 2008 Volume: 10

Year: 2007 Volume: 9

Glucose control in non-critically ill inpatients with diabetes: towards closed-loop.

Content Provider	World Health Organization (WHO)-Global Index Medicus
Author	Thabit, H. Hovorka, R.
Description	Country affiliation: United kingdom Author Affiliation: Thabit H ( Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.)
Abstract	Inpatient glycaemic control remains an important issue due to the increasing number of patients with diabetes admitted to hospital. Morbidity and mortality in hospital are associated with poor glucose control, and cost of hospitalization is higher compared to non-diabetes patients. Guidelines for inpatient glycaemic control in the non-critical care setting have been published. Current recommendations include basal-bolus insulin therapy, regular glucose monitoring, as well as enhancing healthcare provider's role and knowledge. In spite of growing focus, implementation in practice is limited, mainly due to increasing workload burden on staff and fear of hypoglycaemia. Advances in healthcare technology may contribute to an improvement of inpatient diabetes care. Integration of glucose measurements with healthcare records and computerized glycaemic control protocols are currently being used in some institutions. Recent interests in continuous glucose monitoring have led to studies assessing its utilization in inpatients. Automation of glucose monitoring and insulin delivery may provide a safe and efficacious tool for hospital staff to manage inpatient hyperglycaemia, whilst reducing staff workload. This review summarizes the evidence on current approaches to managing inpatient glycaemic control; its utility and limitations. We conclude by discussing the evidence from feasibility studies to date, on the potential use of closed loop in the non-critical care setting and its implication for future studies.
File Format	HTM / HTML
ISSN	14628902
Issue Number	6
Volume Number	16
e-ISSN	14631326
Journal	Diabetes, Obesity and Metabolism
Language	English
Publisher	Wiley-Blackwell
Publisher Date	2014-06-01
Publisher Place	Great Britain (UK)
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Discipline Metabolism Discipline Endocrinology Discipline Pharmacology Discipline Diabetology Blood Glucose Drug Effects Diabetes Mellitus, Type 1 Drug Therapy Metabolism Hyperglycemia Insulin Therapeutic Use Humans Hypoglycemic Agents Severity Of Illness Index Journal Article Research Support, N.i.h., Extramural Research Support, Non-u.s. Gov't Review
Content Type	Text
Resource Type	Article
Subject	Endocrinology, Diabetes and Metabolism Internal Medicine Endocrinology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Insulin therapy for the management of hyperglycemia in hospitalized patients.

Insulin requirements in non-critically ill hospitalized patients with diabetes and steroid-induced hyperglycemia.

Closed-loop insulin delivery in type 1 diabetes.

Glycemic control in non-diabetic critically ill patients.

Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes.

Blood glucose response to rescue dextrose in hypoglycemic, critically ill patients receiving an insulin infusion.

Dysglycaemia in the critically ill - significance and management.

The effect of insulin feedback on closed loop glucose control.

Bringing closed-loop home: recent advances in closed-loop insulin delivery.

Glucose control in non-critically ill inpatients with diabetes: towards closed-loop.

Similar Documents

Insulin therapy for the management of hyperglycemia in hospitalized patients.

Insulin requirements in non-critically ill hospitalized patients with diabetes and steroid-induced hyperglycemia.

Closed-loop insulin delivery in type 1 diabetes.

Glycemic control in non-diabetic critically ill patients.

Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes.

Blood glucose response to rescue dextrose in hypoglycemic, critically ill patients receiving an insulin infusion.

Dysglycaemia in the critically ill - significance and management.

The effect of insulin feedback on closed loop glucose control.

Bringing closed-loop home: recent advances in closed-loop insulin delivery.

Glucose control in non-critically ill inpatients with diabetes: towards closed-loop.